You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Interpace Diagnostics to raise $1.7M in offering
L.K. Bennett: Bankruptcy Case Study
State Of Singapore Online Video Subscription
Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition
Episode 43 - More Change, M&A On Horizon For Equity Research Industry
Interpace Diagnostics Group Inc. is issuing 2 million shares and 1.6 million pre-funded warrants to an undisclosed buyer to raise $1.7 million in net proceeds.
The shares are priced at 53 cents apiece while the warrants are exercisable at 52 cents per share.
Maxim Group LLC is the exclusive placement agent for the registered direct offering which is expected to close Dec. 22.
Funds raised will help Interpace meet working capital requirements.